Literature DB >> 29550914

Hip osteonecroses treated with calcium sulfate-calcium phosphate bone graft substitute have different results according to the cause of osteonecrosis: alcohol abuse or corticosteroid-induced.

Andrzej Sionek1, Adam Czwojdziński1, Jacek Kowalczewski2, Tomasz Okoń2, Dariusz Marczak2, Marcin Sibiński3, Marcin Złotorowicz1, Jarosław Czubak1.   

Abstract

INTRODUCTION: The aim of the study was to assess the factors influencing the final results of treatment of the femoral head osteonecrosis (ONFH) with core decompression and bone substitute grafting. The special interest was focused on comparison between alcohol- and steroid-induced ONFHs.
MATERIAL AND METHODS: In this prospective study, a total of 53 patients (58 hips) in the mean age of 35.5 years were included: 29 had a history of alcohol use (32 hips) and 24 of steroid use (26 hips). The mean follow-up was 4.2 years (minimum 3 years).
RESULTS: At last follow-up, significant improvements were noted in the Harris Hip Score (HHS) (mean 44.0 vs 55.9 points, p < 0.00002) and VAS scores (mean 7.0 vs 5.8 points, p < 0.0002) for the whole ONFH cohort, comparing to pre-operative status. The degree of improvement did not differ between Ficat and Arlet grade II and grade III (mean 14.9 vs 6.2 points, respectively, p = 0.1). No change was found between the final and initial results in this group in the steroid group (HHS mean 42.2 vs 45.5 points, p = 0.5 and VAS mean 6.8 vs 6.5 points, p = 0.5), but the improvement was noted in the alcohol group (HHS mean 45.5 vs 64.4 points, p < 0.0001; VAS mean 7.1 vs 5.2 points, p < 0.0001) comparing to pre-operative status.
CONCLUSIONS: Presented treatment of ONFH significantly improves hip function, offers pain reduction, and gives similar functional improvement for hips scoring grade II and III on the Ficat and Arlet scale. A good response to operative treatment is seen in patients with alcohol-induced ONFH, but not in those with steroid-induced ONFH.

Entities:  

Keywords:  Avascular necrosis of femoral head; Calcium phosphate; Calcium sulfate; Mini-invasive treatment; Rehabilitation

Mesh:

Substances:

Year:  2018        PMID: 29550914     DOI: 10.1007/s00264-018-3892-0

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  26 in total

Review 1.  Classification systems for osteonecrosis: an overview.

Authors:  Marvin E Steinberg; David R Steinberg
Journal:  Orthop Clin North Am       Date:  2004-07       Impact factor: 2.472

2.  Bone morphogenetic proteins (BMPs): from morphogens to metabologens.

Authors:  A Hari Reddi; Anand Reddi
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-08       Impact factor: 7.638

3.  Imaging the vascularisation of the femoral head by CT angiography.

Authors:  M Zlotorowicz; J Czubak; P Kozinski; R Boguslawska-Walecka
Journal:  J Bone Joint Surg Br       Date:  2012-09

4.  The blood supply to the femoral head after posterior fracture/dislocation of the hip, assessed by CT angiography.

Authors:  M Zlotorowicz; J Czubak; A Caban; P Kozinski; R Boguslawska-Walecka
Journal:  Bone Joint J       Date:  2013-11       Impact factor: 5.082

5.  Adenovirus-Mediated Expression of BMP-2 and BFGF in Bone Marrow Mesenchymal Stem Cells Combined with Demineralized Bone Matrix For Repair of Femoral Head Osteonecrosis in Beagle Dogs.

Authors:  Wu-Xun Peng; Lei Wang
Journal:  Cell Physiol Biochem       Date:  2017-10-18

Review 6.  Which factors influence preservation of the osteonecrotic femoral head?

Authors:  Jay R Lieberman; Stephen M Engstrom; R Michael Meneghini; Nelson Fong SooHoo
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

Review 7.  Analysis of Cell Therapies Used in Clinical Trials for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature.

Authors:  Nicolas S Piuzzi; Jorge Chahla; Hao Jiandong; Morad Chughtai; Robert F LaPrade; Michael A Mont; George F Muschler; Cecilia Pascual-Garrido
Journal:  J Arthroplasty       Date:  2017-03-15       Impact factor: 4.757

8.  Tantalum rod implantation for femoral head osteonecrosis: survivorship analysis and determination of prognostic factors for total hip arthroplasty.

Authors:  Yaosheng Liu; Liang Yan; Shiguo Zhou; Xiuyun Su; Yuncen Cao; Cheng Wang; Shubin Liu
Journal:  Int Orthop       Date:  2015-08-11       Impact factor: 3.075

9.  One-sided hip-preserving and concurrent contralateral total hip arthroplasty for the treatment of bilateral osteonecrosis of the femoral head in different stages: short-medium term outcomes.

Authors:  Yirong Zeng; Xinyu Qi; Wenjun Feng; Jie Li; Feilong Li; Jianchun Zeng; Chunzhi Yi; Jinlun Chen
Journal:  BMC Musculoskelet Disord       Date:  2015-06-05       Impact factor: 2.362

10.  Investigating Clinical Failure of Bone Grafting through a Window at the Femoral Head Neck Junction Surgery for the Treatment of Osteonecrosis of the Femoral Head.

Authors:  Wei Zuo; Wei Sun; Dingyan Zhao; Fuqiang Gao; Yangming Su; Zirong Li
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

View more
  12 in total

1.  Hip osteonecrosis: stem cells for life or behead and arthroplasty?

Authors:  Philippe Hernigou; Gildasio Daltro; Jacques Hernigou
Journal:  Int Orthop       Date:  2018-06-08       Impact factor: 3.075

Review 2.  The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head: indications, techniques, and outcomes.

Authors:  Assem A Sultan; Anton Khlopas; Peter Surace; Linsen T Samuel; Mhamd Faour; Nipun Sodhi; Viktor E Krebs; Kim L Stearns; Robert M Molloy; Michael A Mont
Journal:  Int Orthop       Date:  2018-07-23       Impact factor: 3.075

3.  Global urinary metabolic profiling of the osteonecrosis of the femoral head based on UPLC-QTOF/MS.

Authors:  Gang Yang; Gang Zhao; Jian Zhang; Sichuan Gao; Tingmei Chen; Shijia Ding; Yun Zhu
Journal:  Metabolomics       Date:  2019-02-20       Impact factor: 4.290

4.  Minimally Invasive Treatment for Unicameral Bone Cysts with Chemical Sclerosis and Bone Graft Substitute: A Preliminary Report.

Authors:  Shankar Rajeswaran; Ali Khan; Jonathan D Samet; James Donaldson; Samer Attar; Terrance Peabody; Jared Green
Journal:  Cardiovasc Intervent Radiol       Date:  2021-10-10       Impact factor: 2.740

5.  Comparison of the outcome of different bone grafts combined with modified core decompression for the treatment of ARCO II stage femoral head necrosis.

Authors:  Junming Wan; Yanqing Hu; Jiachun Li; Yuqing Zeng; Haiyong Ren
Journal:  Int Orthop       Date:  2022-05-10       Impact factor: 3.479

6.  Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side.

Authors:  Philippe Hernigou; Benjamin Thiebaut; Victor Housset; Claire Bastard; Yasuhiro Homma; Younes Chaib; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

7.  Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients.

Authors:  Philippe Hernigou; Arnaud Dubory; Yasuhiro Homma; Isaac Guissou; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Hélène Rouard
Journal:  Int Orthop       Date:  2018-05-09       Impact factor: 3.075

8.  Study on the outcome of patients with aseptic femoral head necrosis treated with percutaneous multiple small-diameter drilling core decompression: a retrospective cohort study based on magnetic resonance imaging and equivalent sphere model analysis.

Authors:  Yang Tan; Hangyuan He; Zihao Wan; Jun Qin; Yinxian Wen; Zhengqi Pan; Hua Wang; Liaobin Chen
Journal:  J Orthop Surg Res       Date:  2020-07-15       Impact factor: 2.359

9.  Modified trapdoor procedures using autogenous tricortical iliac graft without preserving the broken cartilage for treatment of osteonecrosis of the femoral head: a prospective cohort study with historical controls.

Authors:  Qi Cheng; Feng-Chao Zhao; Shi-Zhuang Xu; Li Zheng; Xin Zheng
Journal:  J Orthop Surg Res       Date:  2020-05-24       Impact factor: 2.359

10.  Unusual indication of Cell therapy for hip osteonecrosis after pregnancy.

Authors:  Philippe Hernigou; Guillaume Rigoulot; Jean Charles Auregan; Victor Housset; Claire Bastard; Arnaud Dubory; Charles Henri Flouzat Lachaniette
Journal:  SICOT J       Date:  2018-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.